Thu, April 22, 2021
Wed, April 21, 2021
Tue, April 20, 2021
Mon, April 19, 2021
Fri, April 16, 2021
Thu, April 15, 2021

David Lewis Maintained (BVS) at Buy with Increased Target to $19 on, Apr 19th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-19-on-apr-19th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Lewis of Morgan Stanley, Maintained "Bioventus Inc." (BVS) at Buy with Increased Target from $18 to $19 on, Apr 19th, 2021.

David has made no other calls on BVS in the last 4 months.



There are 3 other peers that have a rating on BVS. Out of the 3 peers that are also analyzing BVS, 0 agree with David's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with David


  • Amit Hazan of "Goldman Sachs" Initiated at Strong Buy and Held Target at $19 on, Monday, March 8th, 2021
  • Kyle Rose of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $23 on, Monday, March 8th, 2021
  • Robbie Marcus of "JP Morgan" Initiated at Buy and Held Target at $17 on, Monday, March 8th, 2021

Publication Contributing Sources